The intracerebral injection of TWEAK induces MMP-9 activation, and either genetic deficiency of Fn14, or treatment with Fn14-Fc decoy inhibits cerebral ischemia-induced MMP-9 activation. This evidence concerns the gene TNFRSF12A and brain ischemia.